Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Intangibles (2016 - 2025)

INVO Fertility has reported Intangibles over the past 16 years, most recently at $1.4 million for Q3 2025.

  • Quarterly Intangibles fell 58.9% to $1.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Sep 2025, down 58.9% year-over-year, with the annual reading at $3.3 million for FY2024, 19.97% down from the prior year.
  • Intangibles was $1.4 million for Q3 2025 at INVO Fertility, down from $1.5 million in the prior quarter.
  • Over five years, Intangibles peaked at $17.9 million in Q1 2025 and troughed at $20909.0 in Q3 2021.
  • The 5-year median for Intangibles is $1.5 million (2025), against an average of $2.6 million.
  • The largest YoY upside for Intangibles was 1406.14% in 2021 against a maximum downside of 73.1% in 2021.
  • A 5-year view of Intangibles shows it stood at $132093.0 in 2021, then increased by 0.44% to $132679.0 in 2022, then skyrocketed by 2985.21% to $4.1 million in 2023, then decreased by 19.97% to $3.3 million in 2024, then tumbled by 56.33% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Intangibles are $1.4 million (Q3 2025), $1.5 million (Q2 2025), and $17.9 million (Q1 2025).